
Jeff D. Prescott , PharmD, RPh
Advertisement
Articles by Jeff D. Prescott , PharmD, RPh


Multiple sclerosis (MS) is a disease of inflammatory demyelination of axons of the central nervous system that results in episodes of transient neurologic deficits, progressing to permanent neurologic deterioration over time.1 The cause of MS remains unclear, but it is thought to involve both genetic susceptibility and environmental triggers, possibly viral, which result in self-sustaining autoimmune dysfunction.

Advertisement
Latest Updated Articles
Considerations for the Pharmacist About Anaphylaxis and Epinephrine Auto-InjectorsPublished: June 19th 2015 | Updated:
Waste Not, Want Not: Drug Disposal and the Role of the PharmacistPublished: February 19th 2010 | Updated:
Initiating Drug Therapy in Multiple Sclerosis Patients: Effect on Healthcare CostsPublished: April 6th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
FDA Approves Gene Replacement Therapy Itvisma for Patients With Spinal Muscular Atrophy
3
Navigating Migraine Management and the Role of Symbravo in Acute Treatment
4
Update on Novel Antimicrobials and Their Uses
5





